label: Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 3
label_lc: introduction of cytarabine and daunorubicin liposome antineoplastic into central vein, percutaneous approach, new technology group 3